Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...

Codoxo, the leading provider of artificial intelligence solutions in payment integrity and cost containment for healthcare payers, government agencies and pharmacy benefit managers, is pleased to ...

In this interview, NewsMedical speaks with Esther Kieserman and Arvonn Tully from Yokogawa Life Science about how ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus ...

Regulators in the U.S. and the European Union agreed to review Biogen’s applications for approval of a higher dose Spinraza ...

Andie MacDowell is battling a painful neuromuscular disorder. "I have piriformis syndrome, so it's a muscle that kind of clamps down on my sciatic nerve, and it was shooting down my leg ...

After an overnight fast during bedtime, our bodies need breakfast to refuel and function at our best. The best combination is ...

One of the first descriptions of the use of NIV using nasal masks was for the treatment of hypoventilation at night in patients with neuromuscular disease. 1, 2 This has proved to be so successful ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...